Sixth Early Fetal Scan Hybrid Conference 2023

This year, we are delighted to present a unique opportunity for fetal medicine, obstetrics and ultrasound professionals, fetal cardiologists and geneticists to gather and explore the latest developments in screening for CHD at 10-14 weeks and Early Fetal Echocardiography (eECHO).

Congenital heart disease (CHD) is a major diagnostic and management challenge for fetal medicine specialists, ultrasound professionals, and cardiologists. However, significant advances have been made in our understanding of the early manifestations of CHD: the development of the newest ultrasound technology has made it possible to detect the majority of severe CHD at 10-13 weeks through a simple scanning protocol.

During this conference, we will explore all aspects of early diagnosis, verification, counselling, diagnostic work-up, and management of CHD. We will have an excellent panel of speakers who are experts in the field and who will share their knowledge and expertise with us.

We planned to hold this conference in London in 2020, but it was held virtually due to the pandemic. However, there have been significant advances in first-trimester echocardiography in just three years. This year’s conference’s agenda will be revised to engage with the latest advances in this vital field. The conference will provide practical insights, techniques, and guidance for early diagnosis, verification, counselling, diagnostic work-up, and management of congenital heart defects (CHD).

The conference is designed to be a face-to-face event, allowing you to network with your peers and engage in thought-provoking discussions on the latest developments in this field. We believe that this conference will be an excellent opportunity for you to expand your knowledge, network with colleagues, and share your own experiences.

This year’s conference will serve as a comprehensive summary of the work we have accomplished in developing and promoting first-trimester CHD screening worldwide.

Don’t miss out on this opportunity to attend our final event, learn about the latest developments in early CHD screening and network with colleagues worldwide.

Early diagnosis and management of congenital heart defects:

• 12 reasons why screening for CHD at 10-11 or 12-14 weeks is preferable to at 20 weeks
• First-trimester screening for CHD and Early Echocardiography: what is the difference?
• Role of fetal cardiologist in early detection of CHD: working together
• Meta-analysis and systematic review: Performance of CHD screening (2022)
• FMF publications on CHD screening
• Updated ISUOG Practice Guidelines: Performance of 11-14-week ultrasound scan (2023)
• Early screening for CHD and referral pathways
• 10 weeks CHD screening: New approach and future pathways
• SlowflowHD: Revolution in Doppler imaging
• ISUOG guidelines on ultrasound safety: urgent need for correction
• NT, DV, TR and other surrogate markers: their role in CHD screening
• The technique of cardiac examination at 10-11 and 12-14 weeks
• Transabdominal and transvaginal cardiac scan
• Common patterns of CHD in the 1st trimester
• Missed TGA in the first trimester: Lessons from mistakes
• Common CHD: All the spectrum
• Rare CHD: Dozens of unusual cardiac anomalies
• CHD detectable only in the 1st trimester
• Main limitations of cardiac scan at 10-14 weeks
• Human genetic and early detection of CHD
• 22q11 deletion screening
• Role of exome in CHD
• Management of pregnancy with early diagnosis of CHD
• 4 clinical scenarios of CHD presentation
• How to implement 1st trimester CHD screening in the UK and worldwide?

* Please note that the Faculty and the final program of the Conference will be  published later.

Please note this is copyright protected material: © 2017-2023
London School of Ultrasound is registered trademark.